NCT00953745 Dopaminergic Effects of Adjunctive Aripiprazole on the Brain in Treatment-Resistant Depression Status COMPLETED Phase NA
NCT00949988 A Study of Dasatinib and Rituximab for Relapsed/Refractory Chronic Lymphocytic Leukemia Status TERMINATED Phase PHASE1/PHASE2
NCT00949767 Safety, Pharmacokinetics and Pharmacodynamics Study of BMS-866949 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT00948389 Study of CCNU (Lomustine) Plus Dasatinib in Recurrent Glioblastoma (GBM) Status TERMINATED Phase PHASE1/PHASE2
NCT00944905 Study of MDX-1203 in Subjects With Advanced/Recurrent Clear Cell Renal Cell Carcinoma (ccRCC) or Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL) Status COMPLETED Phase PHASE1
NCT00940771 Equivalence of Boosted Atazanavir Based Regimens and Currently Effective HAART Regimens Status COMPLETED Phase PHASE4
NCT00940524 Induction Therapy With Cytarabine, High-Dose Mitoxantrone and Dasatinib for Patients With Philadelphia-Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia Status COMPLETED Phase PHASE1
NCT00931801 BATAR: Individuals Currently Taking Boosted Atazanavir as Part of an HIV Treatment Regimen Will be Evaluated to See if Substituting Raltegravir for Nucleoside Transcriptase Inhibitors Will be Safe and Well Tolerated. Status COMPLETED Phase PHASE4
NCT00930865 Study to Evaluate the Potential Pharmacokinetic Interaction and Pharmacodynamic Effects on Renal Parameters of Bumetanide (1mg) and Dapagliflozin (10 mg) When Co-administered in Healthy Subjects Status COMPLETED Phase PHASE1
NCT00927875 A Study of BMS-833923 With Carboplatin and Etoposide Followed by BMS-833923 Alone in Subjects With Extensive-Stage Small Cell Lung Cancer Status COMPLETED Phase PHASE1
NCT00926757 Prophylactic Use of Entecavir for Non-Hodgkin's Lymphoma Patients With Resolved Hepatitis B Status COMPLETED Phase PHASE4
NCT00924898 Treatment of Acute HIV With Emtricitabine, Tenofovir and Efavirenz (CID 0805) Status COMPLETED Phase PHASE4
NCT00924352 Trial of Dasatinib Plus Ixabepilone in 2nd or 3rd Line Metastatic Breast Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00920907 Comparison of Ipilimumab Manufactured by 2 Different Processes in Participants With Advanced Melanoma Status COMPLETED Phase PHASE1
NCT00920868 XAD - Xelox (Capecitabine + Oxaliplatin) + Bevacizumab + Dasatinib Status COMPLETED Phase PHASE1
NCT00918879 Evaluate Saxagliptin in Adult Indian Patients With Type 2 Diabetes Inadequate Glycemic Control Status COMPLETED Phase PHASE3